Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures

scientific article

Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEUROPHARM.2016.04.016
P932PMC publication ID4920646
P698PubMed publication ID27085605
P5875ResearchGate publication ID301287933

P50authorVincenzo CrunelliQ61978377
François DavidQ83410831
Giuseppe Di GiovanniQ42469477
P2093author name stringCristiano Bombardi
Marcello Venzi
Anna Cavaccini
Joachim Bellet
P2860cites workCortical control of generalized absence seizures: effect of lidocaine applied to the somatosensory cortex in WAG/Rij ratsQ48882222
Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortexQ73280252
Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodentsQ77608922
FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological dataQ21296817
Functional Selectivity and Classical Concepts of Quantitative PharmacologyQ22242288
HallucinogensQ22251224
Identification of a serotonin/glutamate receptor complex implicated in psychosisQ24655484
Opportunities for improving animal welfare in rodent models of epilepsy and seizuresQ26786226
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A ReceptorsQ27347603
Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Q28080944
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptorsQ28119146
Molecular, pharmacological and functional diversity of 5-HT receptorsQ28206145
Genetic absence epilepsy in rats from Strasbourg--a reviewQ28260153
1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonistsQ28263375
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategiesQ28293380
Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramineQ28366550
Contribution of transient receptor potential channels to the control of GABA release from dendritesQ28510991
Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortexQ28567004
Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the ratQ28570127
The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizuresQ30273949
5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in miceQ30484420
Enhanced tonic GABAA inhibition in typical absence epilepsy.Q30493216
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movementQ30559794
The control of seizures by the basal ganglia? A review of experimental data.Q30757339
Childhood absence epilepsy: genes, channels, neurons and networks.Q30835420
The genetic absence epilepsy rat from Strasbourg as a model to decipher the neuronal and network mechanisms of generalized idiopathic epilepsiesQ30970461
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis studyQ33864659
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of respondingQ34154263
Investigating local and long-range neuronal network dynamics by simultaneous optogenetics, reverse microdialysis and silicon probe recordings in vivoQ34185595
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonistQ34432766
Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors.Q34474361
Activity Modes in Thalamocortical Relay Neurons are Modulated by G(q)/G(11) Family G-proteins - Serotonergic and Glutamatergic SignalingQ34508357
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activityQ34562888
Dopamine and serotonin receptor binding and antipsychotic efficacyQ34605995
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterizationQ34746665
5-HT2C receptor agonists: pharmacological characteristics and therapeutic potentialQ34750267
Molecular biology of 5-HT receptorsQ34788155
The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysisQ35007677
Symptoms of anxiety and depression in childhood absence epilepsyQ35132044
Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of ratsQ35566188
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsyQ35693028
Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugsQ36002948
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.Q36126606
Selective 5HT2A and 5HT6 receptor antagonists promote sleep in ratsQ36427038
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addictionQ36540945
Sleep and epilepsy: a summary of the 2011 merritt-putnam symposiumQ36623350
Serotonin and epilepsyQ36703063
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profileQ36798643
Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response modelQ37125668
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studiesQ37260873
Serotonin-dopamine interaction: electrophysiological evidenceQ37260878
The WAG/Rij strain: A genetic animal model of absence epilepsy with comorbidity of depressionyQ37811198
Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulationQ37834732
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonistsQ38138298
Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor fieldQ38150698
The role of different serotonin receptor subtypes in seizure susceptibility.Q38162732
A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures.Q38268879
Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex.Q38299958
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disordersQ38652598
Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-proteinQ40367280
‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity☆Q40665037
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonistQ41081403
Anticonvulsant compounds and 5-hydroxytryptamine in rat brainQ42089853
Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbensQ42175158
The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.Q42435261
Serotonergic projections and serotonin receptor expression in the reticular nucleus of the thalamus in the rat.Q42483776
Neuromodulatory role of serotonin in the ferret thalamusQ42519692
Activation of 5-HT2A receptors by TCB-2 induces recurrent oscillatory burst discharge in layer 5 pyramidal neurons of the mPFC in vitroQ42736308
Serotonergic modulation of absence-like seizures in groggy rats: a novel rat model of absence epilepsyQ42927017
Differences in response to serotonergic activation between first and higher order thalamic nucleiQ43076307
Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific.Q43188186
Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neuronesQ43450968
A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h).Q43548350
Neurotransmission in rats' spontaneous generalized nonconvulsive epilepsyQ44006385
Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependenceQ44106343
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brainQ44247651
Is spontaneous high-voltage rhythmic spike discharge in Long Evans rats an absence-like seizure activity?Q44491434
5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsyQ44760160
Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.Q44872295
The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat modelQ44879166
Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neuronsQ44885392
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletionQ44962619
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeysQ45243882
Epilepsy and obesity in serotonin 5-HT2C receptor mutant miceQ46069611
Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profilesQ46240693
Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortexQ46477242
Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalamiQ46788524
Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current.Q46842339
Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causationQ46893789
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons.Q46902119
Serotonin depletion attenuates AY-9944-mediated atypical absence seizures.Q46962018
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychoticsQ47646787
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized ratsQ47856836
The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat.Q47976192
Unique expression patterns of 5-HT2A and 5-HT2C receptors in the rat brain during postnatal development: Western blot and immunohistochemical analysesQ48108957
Deep layer somatosensory cortical neurons initiate spike-and-wave discharges in a genetic model of absence seizures.Q48136760
Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysisQ48313604
Pathophysiological mechanisms of genetic absence epilepsy in the rat.Q48461890
Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain developmentQ48477424
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatementQ48655865
P304page(s)292-304
P577publication date2016-04-13
P1433published inNeuropharmacologyQ15332439
P1476titleRole for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
P478volume108

Reverse relations

cites work (P2860)
Q39164871A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
Q90395863Acute and Chronic Nicotine Exposures Differentially Affect Central Serotonin 2A Receptor Function: Focus on the Lateral Habenula
Q57468371Current Treatment Strategies and Future Treatment Options for Dravet Syndrome
Q97883048Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
Q58694358Lorcaserin therapy for severe epilepsy of childhood onset: A case series
Q48026143Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products
Q28074736Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
Q56352717Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence
Q61946884Suppression of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Function in Thalamocortical Neurons Prevents Genetically Determined and Pharmacologically Induced Absence Seizures
Q92176310Trazodone increases seizures in a genetic WAG/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model
Q42577060Updating neuropathology and neuropharmacology of monoaminergic systems

Search more.